--2024/Q4-- / 15.825M--
--2024/Q3-- / 14.650M--
Aug 8, 20242024/Q214.519M / 14.175M--
May 9, 20242024/Q112.473M / 14.675M--
Mar 14, 20242023/Q415.863M / 16.067M--
CA Stock MarketDetailed Quotes
HLS HLS Therapeutics Inc
- 3.320
- +0.020+0.61%
15min DelayMarket Closed Aug 30 16:00 ET
105.55MMarket Cap-3235P/E (TTM)
3.400High3.320Low6.60KVolume3.360Open3.300Pre Close22.39KTurnover5.52052wk High0.04%Turnover Ratio31.79MShares3.00052wk Low-1.026EPS TTM53.91MFloat Cap24.598Historical HighLossP/E (Static)16.24MShs Float0.043Historical Low-1.127EPS LYR2.42%Amplitude--Dividend TTM0.95P/B1Lot Size--Div YieldTTM
HLS Therapeutics Inc Key Stats
HLS Therapeutics Inc Q2 2024 Earnings Date
Currency：USDAug 8, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 14.18M | 14.52M | +344.00K |
| Beat Est. | -13.66% | -11.56% | +2.43% |
| EPS | -0.18 | -0.18 | -<0.01 |
| Miss Est. | +37.94% | +37.93% | -0.06% |
HLS Therapeutics Inc Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Heat List
CA
Overall
Symbol
Latest Price
% Chg